LKT Labs

Biochemicals for Life Science Research

Montelukast Sodium

Montelukast Sodium

Product ID M5756
Cas No. 151767-02-1
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $82.00 In stock
25 mg $130.00 In stock
100 mg $375.00 In stock
Bulk Quote

Quicklinks

Description

Montelukast is an antagonist at cysteinyl leukotriene 1(CysLT1) receptors; it exhibits anti-allergic, anti-asthma, anti-inflammatory, analgesic, anti-tussive, and bronchodilatory activities. Montelukast is clinically used to treat allergic rhinitis and asthma, although it also attenuates cough and decreases eosinophil infiltration. Montelukast decreases expression of p38 MAPK, NF-κB, IL-1β, IL-6, and TNF-α and inhibits activation of microglia, attenuating neuropathic pain in animal models of chronic constrictive injury (CCI).

Product Info

Cas No.

151767-02-1
Purity

≥98%
Formula

C35H35ClNO3S Na
Formula Wt.

608.17
Chemical Name

1-((((1R)-1-(3-((1E)-2-(7-chloro-2- quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1- methylethyl)phenyl)propyl)thio)methyl)-Cyclopropaneacetic acid, monosodium salt
IUPAC Name

sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3- [2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl] acetate
Synonym

Singulair
Solubility

Soluble in ethanol, DMSO.
Appearance

Off-white to pale yellow hygroscopic powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

M5756 MSDS PDF
Info Sheet

M5756 Info Sheet PDF

References

Zhou C, Shi X, Huang H, et al. Montelukast Attenuates Neuropathic Pain Through Inhibiting p38 Mitogen-Activated Protein Kinase and Nuclear Factor-Kappa B in a Rat Model of Chronic Constriction Injury. Anesth Analg. 2014 May;118(5):1090-6. PMID: 24686047.

Niimi A. Cough, asthma, and cysteinyl-leukotrienes. Pulm Pharmacol Ther. 2013 Oct;26(5):514-9. PMID: 23774534.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • R3224

    Rigin

    Peptide, IgG derivative, tuftsin analog.

    ≥95%
  • T3035

    Thienylheptyl Isothiocyanate

    Thienylbutyl ITC analog.

    ≥95%
  • A5133

    Amiloride Hydrochloride Dihydrate

    K+-sparing diuretic; ENaC and acid-sensing ion ...

    ≥98%
  • A5039

    Amitraz

    Insecticide; α-adrenergic agonist, MAO inhibit...

    ≥97%
  • G4581

    Glucosamine Sulfate Potassium Chloride

    Endogenous amino acid sugar involved in cartila...

    ≥98%
  • C2818

    Chelerythrine Chloride

    benzophenanthridine alkaloid found in Chelidoni...

    ≥98%
  • G8850

    GW-5074

    c-Raf inhibitor.

    ≥98%
  • N3210

    Nicergoline

    Ergot derivative found in Claviceps; α1-adrene...

    ≥98%
  • R2513

    RGDS

    Tetrapeptide, binds cell surface integrins.

    ≥95%
  • A480010

    AM630

    CB2 receptor antagonist.

    ≥97%
  • C1650

    β-Cembrenediol Methyl Ether

    Diterpene found in tobacco plants and cigarette...

    ≥98%
  • D1621

    Deferasirox

    Iron chelator.

    ≥99%
  • Z1602

    Zearalenone

    Mycotoxin produced by Fusarium; ER agonist.

    ≥98%
  • O9210

    Oxcarbazepine

    α4β2 nAChR desensitizer, delayed-rectifier vo...

    ≥98%
  • T2792

    TGX-221

    p110β PI3K inhibitor.
  • S8009

    Substance P (7-11)

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • P0369

    Parecoxib Sodium

    NSAID; COX-2 inhibitor.

    ≥99%
  • C3210

    Ciglitazone

    Thiazolidinedione; PPARγ agonist.

    ≥98%
  • D3362

    Dipyridamole

    PDE and adenosine deaminase inhibitor.

    ≥98%
  • A0101

    4-bromo-A23187

    Non-fluorescent halogenated A23187 analog, Ca2+...

    ≥98%